Cat. No. | Product name | CAS No. |
DC10670 |
CNQX
Featured
CNQX is a potent AMPA/kainate receptor antagonist. Also antagonist at glycine modulatory site on NMDA receptor complex. |
115066-14-3 |
DC23180 |
CNV1014802(Raxatrigine)
Featured
CNV1014802 (GSK-1014802, Raxatrigine, Vixotrigine, BIIB074) is a potent, selective Nav1.7 sodium channel blocker, shows analgesic effects and potential in the treatment of cognitive symptoms of schizophrenia in vivo. |
934240-30-9 |
DC8095 |
Raxatrigine hydrochloride
Featured
CNV1014802(GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor. |
934240-31-0 |
DC7105 |
CNX-2006
Featured
CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR. |
1375465-09-0 |
DC7161 |
CNX-774
Featured
CNX-774 is a potent, selective, and orally available small molecule inhibitor of Btk (IC50< 1 nM) that forms a ligand-directed covalent bond with Cys-481, a non-conserved amino acid within the active site of the enzyme. |
1202759-32-7 |
DC8651 |
CO-1686 hydrobromide
Featured
CO-1686 hydrobromide is a novel, irreversible and orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M (IC50=21 nM). |
1446700-26-0 |
DC7106 |
Rociletinib (CO-1686)
Featured
CO-1686 is a novel, irreversible and orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M(IC50=21 nM). |
1374640-70-6 |
DC2046 |
Cobicistat (GS-9350)
Featured
Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM. |
1004316-88-4 |
DC8863 |
Coelenterazine
Featured
Coelenterazine is a luminescent enzyme substrate, used for monitoring reporter genes in BRET, ELISA and HTS techniques. |
55779-48-1 |
DC10336 |
Coenzyme Q9
Featured
Coenzyme Q9, a nine isoprenyl group-containing member of the ubiquinone family, is a normal constituent of human plasma. |
303-97-9 |
DC11955 |
Takeda compound 101
Featured
Compound 101 (GRK2 inhibitor 101, Takeda compound 101, Cmpd101) is a novel membrane-permeable, small-molecule inhibitor of GRK2 and GRK3. |
865608-11-3 |
DC2085 |
Compound 401
Featured
Compound 401 is a cell-permeable pyrimido-isoquinolinone compound that acts as a potent, reversible, and ATP-competitive inhibitor of DNA-PK (IC50 = 280 nM) with ~19-fold selectivity over FRAP (mTOR) (IC50 = 5.3 µM). |
168425-64-7 |
DC8340 |
myo-Inositol,1,2-anhydro-
Featured
Conduritol B Epoxide (CBE) is a specific covalent inhibitor of β-glucosidase which results in the accumulation of glucocerebroside. |
6090-95-5 |
DCAPI1091 |
Conivaptan hydrochloride
Featured
Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively. |
168626-94-6 |
DC8477 |
VER-49009
Featured
Consistent with inhibition of Hsp90, VER-49009 induces the expression of Hsp27 and Hsp72 while reducing the client proteins C-RAF, B-RAF, survivin, and PRMT5, causing cell cycle arrest and apoptosis. |
558640-51-0 |
DC10776 |
Cordycepin
Featured
Cordycepin is an adenosine analogue, which is readily phosphorylated to its mono-, di-, and triphosphate intracellularly. It has a very potent anti-cancer, anti-oxidant and anti-inflammatory activities. |
73-03-0 |
DC12098 |
Corin
Featured
Corin is a dual inhibitor of histone lysine specific demethylase (LSD1) and histone deacetylase (HDAC), with a Ki(inact) of 110 nM for LSD1 and an IC50 of 147 nM for HDAC1. |
1808113-09-8 |
DC11104 |
Tildacerfont
Featured
corticotropin releasing factor (CRF) antagonist. |
1014983-00-6 |
DC22488 |
Corticotropin-releasing factor (human)
Featured
Corticotropin-releasing hormone (CRH) is a peptide hormone involved in the stress response.. |
86784-80-7 |
DC23908 |
Cortisone
Featured
Cortisone is a pregnane (21-carbon) steroid hormone, one of the main hormones released by the adrenal gland in response to stress. |
53-06-5 |
DC10686 |
Cosan-528
Featured
Cosan-528 is a bioactive chemical. |
96686-51-0 |
DC10657 |
COTI-2
Featured
COTI-2 is a small molecule candidate anti-cancer drug which can convert mutant p53 to wild-type conformation. |
1039455-84-9 |